Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amin Shahsavani"'
Autor:
Ahmad Akbari, Sezaneh Haghpanah, Hamide Barzegar, Amin Shahsavani, Abdolreza Afrasiabi, Shirin Parand, Mehran Karimi
Publikováno v:
Heliyon, Vol 7, Iss 8, Pp e07734- (2021)
Background and aim: Thromboembolic events mainly occur in older age is related with high morbidity and mortality, and considerable health-care costs particularly in developing countries. Both arterial and venous thromboembolism has known risk factors
Externí odkaz:
https://doaj.org/article/60f7c10a85984fcaa855acb5fc72d896
Autor:
Bita Divsalar, Tahereh Kalantari, Soheila Mohebbi, Ardeshir Bahmanimehr, Amin Shahsavani, Afshin Borhani-Haghighi
Publikováno v:
Laboratory medicine.
Objective The main concern about measuring the concentration of rivaroxaban by anti-Xa assay in some laboratories is the lack of a commercial specific calibrator in emergencies. Therefore, this study aimed at providing a homemade anti-Xa calibrator a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af9617112f10a016c309c305fb132bec
https://pubmed.ncbi.nlm.nih.gov/36573788
https://pubmed.ncbi.nlm.nih.gov/36573788
Autor:
Abdolreza Afrasiabi, Shirin Parand, Hamide Barzegar, Mehran Karimi, Amin Shahsavani, Sezaneh Haghpanah, Ahmad Akbari
Publikováno v:
Heliyon
Heliyon, Vol 7, Iss 8, Pp e07734-(2021)
Heliyon, Vol 7, Iss 8, Pp e07734-(2021)
Background and aim Thromboembolic events mainly occur in older age is related with high morbidity and mortality, and considerable health-care costs particularly in developing countries. Both arterial and venous thromboembolism has known risk factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eabd9ba63d8768126a28e0d590b329d
http://europepmc.org/articles/PMC8361253
http://europepmc.org/articles/PMC8361253
Publikováno v:
Blood Transfus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f4bdd0e5a93fc205ed75e747724b56f
https://pubmed.ncbi.nlm.nih.gov/32931418
https://pubmed.ncbi.nlm.nih.gov/32931418
Autor:
Gholamreza Bahoush, Amin Shahsavani, Asghar Bazrafshan, Ali Jangjou, Shahla Ansari, Mehran Karimi, Azita Azarkeivan, Sezaneh Haghpanah
Publikováno v:
Journal of pediatric hematology/oncology. 42(1)
Deferasirox is a once-daily oral iron-chelation agent approved by the US Food and Drug Administration in November 2005. The authors aimed to evaluate efficacy, safety, and satisfaction of patients regarding twice-daily dose of deferasirox in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75ee109979412f0082cfe560f0f23400
https://pubmed.ncbi.nlm.nih.gov/31568183
https://pubmed.ncbi.nlm.nih.gov/31568183
Autor:
Mehran Karimi, Javad Dehbozorgian, Sezaneh Haghpanah, Saeed Daryanoush, Jaber Imani fard, Mohamad Moghadam, Amin Shahsavani, Azam Aramesh
Publikováno v:
Hematology. 20:359-362
Alpha-thalassemia as one of the most common monogenetic disorders is widely spread over the Mediterranean, Southeast Asian, and Middle Eastern populations, including Iran. Although beta-thalassemia is much more common than alpha-thalassemia, alpha-th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f4a70ca74369314e4a7e569899612f
https://doi.org/10.1179/1607845414y.0000000227
https://doi.org/10.1179/1607845414y.0000000227